EPB41L5 and breast carcinoma: Moreover, EPB41L5, which was originally identified as being induced during the epithelial–mesenchymal transition of mammary epithelial cells13, is frequently overexpressed in breast cancer cells as an integral binding partner of AMAP1 that drives invasion and metastasis (will be published elsewhere).